Impaired Transcription in Alzheimer's Disease: Key Role in Mitochondrial Dysfunction and Oxidative Stress

Abstract

Alzheimer's disease (AD) is the major cause of dementia in the world. Abnormal extracellular accumulation of amyloid-β (Aβ) peptide and tau hyperphosphorylation, forming neurofibrillary tangles in the brain, are hallmarks of the disease. Oxidative stress, neuroinflammation, and mitochondrial and synaptic dysfunction are also observed in AD and often correlated to intracellular Aβ. This peptide results from the cleavage of the amyloid-β protein precursor by β- and γ-secretases and tends to be secreted after its production. However, secreted Aβ can be internalized by the interaction with membrane receptors, namely N-methyl-D-aspartate receptors, advanced glycation end products receptors, and/or alpha 7 nicotinic acetylcholine receptors. Inside the cell, Aβ interacts with several organelles, including mitochondria and nucleus, and there is growing evidence pointing to a possible role of Aβ in the regulation of gene transcription. Accordingly, transcriptional deregulation was observed in several AD models and human samples from AD patients through modified expression, phosphorylation levels, function, and subcellular localization of some transcription factors, resulting in the suppression of neuroprotective transcription both in the nucleus and the mitochondria. In this review we focus on key transcription regulators related with mitochondrial biogenesis and antioxidant defenses that seem to be altered in AD models and also on the role of intranuclear Aβ in the pathogenesis of the disease.

Maysin and Its Flavonoid Derivative from Centipedegrass Attenuates Amyloid Plaques by Inducting Humoral Immune Response with Th2 Skewed Cytokine Response in the Tg (APPswe, PS1dE9) Alzheimer’s Mouse Model

“…Oxidative stress is profoundly associated with several metabolic disruptions in AD patients, such as mitochondrial dysfunction and altered activity of mitochondrial cytochrome oxidase, pyruvate dehydrogenase, and α-ketodehydrogenase [39]. Other metabolic disruptions could be associated with oxidative stress in which synaptic dysfunction induced by Aβ is internalized within membrane receptors, such as NMDA, advanced glycation of end-product receptors and/or alpha 7 nicotinic acetylcholine receptors [40]. …”

The relationship between iron dyshomeostasis and amyloidogenesis in Alzheimer's disease: Two sides of the same coin

“…Nrf2 is post-transcriptionally activated by several chemicals, including NO 94 . In Alzheimer’s disease transcription of Nrf2 is impaired and overexpression in an AD mouse model improves spatial memory 95,96 …”

Targeting Microglial KATPChannels to Treat Neurodegenerative Diseases: A Mitochondrial Issue

“…With time, this increase is specific for Kir6.1 and SUR2 components [129], which suggest that A β oligomers induce differential regulations of K ATP subunit neuronal expression. Exposed to A β oligomers, the continuous oxidative stress results in neuronal severe mitochondria dysfunction [130, 131], and the expression changes of K ATP channel components may reflect neuronal attempts to resist the insult in accordance with the metabolic state.…”